// NATURE NEWS — SPAZIO & SCIENZA
Put patients at the centre of medical AI governance
Search author on:
PubMed
Google Scholar
Search author on:
PubMed
Google Scholar
Kyle Lam and his co-authors classify medical artificial intelligence according to autonomy, automation and operational scope, three properties that form a useful basis for setting regulatory and liability boundaries across capability levels (see K. Lam et al. Nature 655, 1129–1132; 2026). They mention informed consent, yet their framework remains centred on allocating responsibility to clinicians, health-care organizations, device manufacturers and regulators. Patient rights receive no systematic place in its design.
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
Prices may be subject to local taxes which are calculated during checkout
When physicians and AI work together, who is accountable? How to lay out medical liability
Medical AI can transform medicine — but only if we carefully track the data it touches
Limit bets on clinical-trial outcomes being placed on prediction markets
Immune therapy engineered inside the body eases multiple sclerosis